Protara Therapeutics, Inc. - Bathi operasional EBITDA TARA
Operating cash flow before interest and taxes exhibits volatility, as the implementation of laboratory robots for molecule screening has not yet stabilized profits. The 0.00 metric indicates a liquidity status that depends on venture capital and the non-cyclical nature of drug development. Meanwhile, outsourcing production to contract organizations allows Protara Therapeutics (TARA) to optimize logistics when treating rare forms of cancer.
Ringkesan rincian data analitis Protara Therapeutics, Inc. (TARA)
- kuotasi saiki lan rata-rata prakiraan nilai:
- rincian nilai pasar emiten:
- indikator nilai buku ekuitas:
- data tingkat utang lan likuiditas finansial:
Utang Agregat marang Ekuitas Protara Therapeutics|TARA - Utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal Protara Therapeutics Inc|TARA - Utang perusahaan|Utang-utang marang nilai buku Protara Therapeutics|TARA - Kewajiban jangka dawa perusahaan|Gedhene kewajiban jangka cendhak Protara Therapeutics|Rasio cepet protaratx.com
- statistik bathi lan rasio pasar:
TARA - Bathi resik perusahaan|Penghasilan resik sing dikarepake Protara Therapeutics|TARA - Pangali P/E|Pangali Forward P/E protaratx.com|TARA - Pangali rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan Protara Therapeutics|TARA - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone patang kuartal pungkasan Protara Therapeutics|TARA - Bathi resik saben saham (EPS TTM)|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan protaratx.com|TARA - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep Protara Therapeutics
Analisis kabeh metrik perusahaan:Protara Therapeutics
This indicator tracks daily operational cash flow, allowing investors to filter out market noise and determine the true trajectory of business development. By analyzing the current EBITDA on the GURU.Markets platform, one can assess the financial stability of Protara Therapeutics (TARA) during a period of costly oncology tests and plastic environmental disposal expenses, which is critical for minimizing the risk of purchasing the asset at its peak.
Analisis pesaing Protara Therapeutics
ONC - Bathi operasional sadurunge ngurangi amortisasi|HALO: Bathi operasional sadurunge ngurangi amortisasi|RVMD - Bathi operasional EBITDA|Ascentage Pharma (AAPG) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|CG Oncology Inc - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|URGN (UroGen) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Bicara Corp BCAX|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Personalis, Inc. (PSNL)|ERAS: Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Delcath Systems DCTH|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi YMAB|AURA - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi Candel Therapeutics|ARAY (Accuray Incorporated) - Bathi operasional sadurunge ngurangi amortisasi|SLS: Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|ACTU (Actuate Therapeutics) - Bathi operasional EBITDA|Bathi operasional EBITDA Citius Oncology Inc.|Bathi sadurunge mbayar bunga, pajak, lan amortisasi TuHURA Biosciences, Inc. (HURA)|FATE (Fate Pharma) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA WHWK (Aadi Bioscience)|Bathi operasional EBITDA TScan Therapeutics Inc TCRX|CSBR: Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi XBIT (XBiotech Inc.)|CVM (cel-sci.com) - Bathi operasional sadurunge ngurangi amortisasi|OSTX: Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|RADX (Radiopharm Theranostics) - Bathi operasional EBITDA|ARTV: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA ANL|VERU - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Tempest Tx TPST|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi XLO|Enochian BioSciences - Bathi operasional EBITDA|MURA - Bathi operasional EBITDA|kairospharma.com (KAPA) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi OKUR (OnKure Therapeutics)|GDTC (CytoMed Therapeutics Ltd) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Curis Corp CRIS|Bathi operasional sadurunge ngurangi amortisasi APLM (Apollomics, Inc.)|Bathi operasional EBITDA tharimmune.com (THAR)|Advanced Biomed - Bathi operasional sadurunge ngurangi amortisasi|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi GNPX (Genprex Inc.)|Calidi Bio - Bathi operasional EBITDA|Pendapatan operasional sadurunge ngurangi amortisasi sunshinebiopharma.com SBFM|XBIO: Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi salariuspharma.com|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Purple Biotech Ltd.|AON (AONC) - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi operasional sadurunge ngurangi amortisasi BGNE (BeOne Medicines)|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi CKPT|Bathi operasional EBITDA ELEV (Elevation Oncology)|Bathi operasional EBITDA iCAD Inc. ICAD|IKNA - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi NTBL (Notable Labs Ltd)|VIRX: Bathi operasional EBITDA|MorphoSys Corporation (MOR) - Bathi operasional EBITDA|NAYA (NAYA Biosciences) - Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi ascentage.com (AAPGV)
